Search Results 1961-1970 of 20534 for Mortality

  1. News Releases - 2023 Archives

    ... Use of anticoagulant drug after aortic valve replacement lowers mortality risk, Mayo Clinic study finds. Jay Furst.

  2. Publications - Jonathan M. Wong, M.D. - Mayo Clinic

    A comparison of cook-medley hostility subscales and mortality in patients with coronary heart disease: data from the heart and soul study. Psychosom Med ...

  3. Amy E. Rabatin, M.D. - Doctors and Medical Staff - Mayo Clinic

    Committee MemberInpatient Rehabilitation Unit Adverse Event and Mortality Committee, Department of Physical Medicine & Rehabilitation. 2018 - present.

  4. Jacob J. Strand, M.D. - Doctors and Medical Staff - Mayo Clinic

    2017 - 2019. MemberMortality Review Committee. 2016 - present. Committee MemberAmerican College of Physicians Medical Knowledge Self-Assessment Program 18. 2016 ...

  5. Reducing post-polypectomy bleeding events in patients who require antithrombotic agents - Mayo Clinic

    Mayo Clinic gastroenterologist Neena S. Abraham, M.D., M.S., reviews research findings related to the use of antithrombotic agents, polypectomy techniques ...

  6. Minnesota - 2023 Archives - Mayo Clinic News Network

    ... Use of anticoagulant drug after aortic valve replacement lowers mortality risk, Mayo Clinic study finds. Jay Furst.

  7. Dr. Rozalina McCoy Archives - Mayo Clinic News Network

    ... mortality in 2020. Older adults and racial and ethnic minority populations, especially Native Americans, were disproportionately affected, according to the ...

  8. Meet Our Fellows - Nurse Practitioner or Physician Assistant Urology Fellowship (Minnesota) - Mayo Clinic College of Medicine & Science

    These include Lunch and Learns, Journal Club, Imaging and Pathology Conferences, Morbidity and Mortality, Guest Lectures, Tumor Board, Stone and ...

  9. Kylie Cooper, M.D. - Doctors and Medical Staff - Mayo Clinic

    2026 - present. MemberAmerican Society of Addiction Medicine · 2025 - present. MemberMinnesota Maternal Mortality Review Committee, Minnesota Department of ...

  10. A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole - Mayo Clinic

    ... mortality (ACM). Furthermore, to demonstrate that treatment of Invasive Candidiasis/ Candidemia with IV echinocandin followed by oral ibrexafungerp is non ...